Renal Cell Injury in Diabetes
Renal Cell Injury in Diabetes
批准号:
7187708
负责人:
Karen Block
金额:
$11.8万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Project Summary. The applicant is completing a post-doctoral fellowship and will assume a position as assistant professor in the tenure track effective 10-1-06. The applicant is applying for this career development award and will be sponsored by two physician scientists with a primary interest in the subject material of this proposal. Both sponsor and co-sponsor are experienced and productive scientists with long standing history of successful graduate students, postdoctoral fellows and junior faculty. Advanced glycation end-products (AGEs) play a central role in the pathogenesis of diabetic complications such as diabetic nephropathy (DN). AGEs stimulate reactive oxygen species (ROS) generation through AGE-specific receptors, which lead to the up-regulation of genes involved in diabetic nephropathy (DN). It has been suggested that ROS generated by the mitochondria electron-transfer chain is the major player in diabetic oxidative stress, however, research in our laboratory find novel NAD(P)H-oxidases, highly expressed in the kidney, to be major sources of ROS in renal hypertrophy and extracellular matrix accumulation (ECM). In preliminary data we show Nox4 localizes to mitochondria as well as plasma membrane. The objective of this grant is to explore the role of AGE-induced oxidative stress in DN. We will first identify the subunits of the NAD(P)H-oxidase(es) that mediate AGE-induced ROS generation which lead to renal hypertrophy and ECM. Secondly, we wish to understand the contribution and cross talk between two major cellular sources of ROS generation, NAD(P)H-oxidases and the mitochondria-electron transfer chain. We will evaluate this novel connection in mesangial cells, the cell of the kidney predominantly involved in hypertrophy and ECM. Finally, in vivo studies will allow us to elucidate the role of NAD(P)H-oxdase(es) and the molecular mechanisms involved in proteinuria, a major complication of DN and an important issue highly relevant for diabetic patients. An attenuation of AGE-induced matrix accumulation and/or protein secretion by delivery of anti-sense NAD(P)H-oxidase injection in the long-term experiments will demonstrate that NAD(P)H-dependent ROS generation contributes not only to the initiation of DN but also to its progression. Our long-term goal is to translate the findings from this research into the discovery of specific inhibitors of ROS generation. The oxdiase will thereby become a primary target for future therapeutic intervention. Our laboratory has the expertise and our University has all the resources available to address the work proposed in this grant.
Relevance. Kidney failure is a common complication of diabetes. Our studies will examine oxidative stress induced by modified proteins (Advanced glycation end products-AGEs) that accumulate in all organs as a result of the diabetic environment. Elucidating these events may allow future modulation of the enzymatic complex(es) to prevent oxidative stress implicated in cellular injury in diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic regulation of diabetic nephropathy
-
批准号:8391640
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Karen Block
-
依托单位:
Metabolic regulation of diabetic nephropathy
-
批准号:8141042
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Karen Block
-
依托单位:
Metabolic regulation of diabetic nephropathy
-
批准号:8696824
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Karen Block
-
依托单位:
Metabolic regulation of diabetic nephropathy
-
批准号:8795671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Karen Block
-
依托单位:
Mechanisms of Renal Carcinogenesis
-
批准号:7526298
-
项目类别:
-
资助金额:$23.57万
-
财政年份:2008
-
负责人:Karen Block
-
依托单位:
Mechanisms of Renal Carcinogenesis
-
批准号:8080903
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2008
-
负责人:Karen Block
-
依托单位:
Mechanisms of Renal Carcinogenesis
-
批准号:7646255
-
项目类别:
-
资助金额:$22.59万
-
财政年份:2008
-
负责人:Karen Block
-
依托单位:
Mechanisms of Renal Carcinogenesis
-
批准号:7845730
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2008
-
负责人:Karen Block
-
依托单位:
Renal Cell Injury in Diabetes
-
批准号:7488474
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2007
-
负责人:Karen Block
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
-
批准号:82102500
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:杨阳
-
依托单位: